Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net loss $ (5,093) $ (5,045)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 42 52
Amortization of right-of-use assets 60 50
Unrealized gain on investment (3) (18)
Share-based compensation expense 302 271
Changes in operating assets and liabilities:    
Other assets 220 179
Trade and other payables 500 293
Accrued employee benefits (11) (8)
Lease liabilities (62) (52)
Net cash used in operating activities (4,045) (4,278)
Cash flows from financing activities:    
Proceeds from issuance of common stock, pre-funded warrants, and common warrants 17,884  
Shares and pre-funded warrant issuance costs (1,869)  
Net cash provided by financing activities 16,015  
Effects of exchange rate changes on cash, cash equivalents, and restricted cash 501 236
Net increase (decrease) in cash, cash equivalents, and restricted cash 12,471 (4,042)
Cash, cash equivalents, and restricted cash, beginning of period 4,076 19,783
Cash, cash equivalents, and restricted cash, end of period 16,547 15,741
Supplemental disclosure of cash flow information:    
Re-measurement of operating lease right-of-use assets and liabilities $ 0 $ 794